SNPs in ERCC1 and drug response to cisplatin in non-small-cell lung cancer patients

被引：0
|
作者：
Osawa, Kayo [1 ]
机构：
[1] Kobe Univ, Fac Hlth Sci, Grad Sch Hlth Sci, Suma Ku, Kobe, Hyogo 6540142, Japan
来源：
PHARMACOGENOMICS | 2011年 / 12卷 / 04期
关键词：
cisplatin; ERCC1; SNP; PLATINUM-BASED CHEMOTHERAPY; SINGLE NUCLEOTIDE POLYMORPHISMS; ADJUVANT CHEMOTHERAPY; EXCISION-REPAIR; DNA-REPAIR; XPD; ASSOCIATION;
D O I：
10.2217/PGS.11.15
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：445 / 447
页数：3
相关论文
共 50 条
  • [1] ERCC1 and non-small-cell lung cancer
    Panasci, Lawrence
    Cohen, Victor
    NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (24): : 2540 - 2540
  • [2] DNA repair by ERCC1 in non-small-cell lung cancer
    Cecere, Fabiana
    Bria, Emilio
    Rosell, Rafael
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (24): : 2590 - 2591
  • [3] ERCC1 and the efficacy of cisplatin in patients with resected non-small cell lung cancer
    Li, Chunhong
    Liu, Meiyan
    Yan, An
    Liu, Wei
    Hou, Junjun
    Cai, Li
    Dong, Xiaoqun
    TUMOR BIOLOGY, 2014, 35 (12) : 12707 - 12712
  • [4] ERCC1 protein expression predicts the response of cisplatin-based neoadjuvant chemotherapy in non-small-cell lung cancer
    Fujii, Tetsuya
    Toyooka, Shinichi
    Ichimura, Kouichi
    Fujiwara, Yoshiro
    Hotta, Katsuyuki
    Soh, Junichi
    Suehisa, Hiroshi
    Kobayashi, Naruyuki
    Aoe, Motoi
    Yoshino, Tadashi
    Kiura, Katsuyuki
    Date, Hiroshi
    LUNG CANCER, 2008, 59 (03) : 377 - 384
  • [5] ERCC1 as Predictor of Platinum Benefit in Non-Small-Cell Lung Cancer
    Postel-Vinay, Sophie
    Soria, Jean-Charles
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04) : 384 - +
  • [6] Association of MDR1 and ERCC1 polymorphisms with response and toxicity to cisplatin-based chemotherapy in non-small-cell lung cancer patients
    Chen, Songjian
    Huo, Xia
    Lin, Yi
    Ban, Hao
    Lin, Yincheng
    Li, Weiqiu
    Zhang, Bao
    Au, William W.
    Xu, Xijin
    INTERNATIONAL JOURNAL OF HYGIENE AND ENVIRONMENTAL HEALTH, 2010, 213 (02) : 140 - 145
  • [7] DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy
    Olaussen, Ken A.
    Dunant, Ariane
    Fouret, Pierre
    Brambilla, Elisabeth
    Andre, Fabrice
    Haddad, Vincent
    Taranchon, Estelle
    Filipits, Martin
    Pirker, Robert
    Popper, Helmut H.
    Stahel, Rolf
    Sabatier, Laure
    Pignon, Jean-Pierre
    Tursz, Thomas
    Le Chevalier, Thierry
    Soria, Jean-Charles
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (10): : 983 - 991
  • [8] Association between polymorphisms of ERCC1 and XPD and survival in non-small-cell lung cancer patients treated with cisplatin combination chemotherapy
    Ryu, JS
    Hong, YC
    Han, HS
    Lee, JE
    Kim, S
    Parke, YM
    Kim, YC
    Hwang, TS
    LUNG CANCER, 2004, 44 (03) : 311 - 316
  • [9] Is ERCC1 a reliable prognostic protein biomarker in non-small-cell lung cancer?
    Durrington, Hannah J.
    THORAX, 2014, 69 (04) : 345 - 345
  • [10] ERCC1 Isoform Expression and DNA Repair in Non-Small-Cell Lung Cancer
    Friboulet, Luc
    Olaussen, Ken Andre
    Pignon, Jean-Pierre
    Shepherd, Frances A.
    Tsao, Ming-Sound
    Graziano, Stephen
    Kratzke, Robert
    Douillard, Jean-Yves
    Seymour, Lesley
    Pirker, Robert
    Filipits, Martin
    Andre, Fabrice
    Solary, Eric
    Ponsonnailles, Florence
    Robin, Angelique
    Stoclin, Annabelle
    Dorvault, Nicolas
    Commo, Frederic
    Adam, Julien
    Vanhecke, Elsa
    Saulnier, Patrick
    Thomale, Juergen
    Le Chevalier, Thierry
    Dunant, Ariane
    Rousseau, Vanessa
    Le Teuff, Gwenael
    Brambilla, Elisabeth
    Soria, Jean-Charles
    NEW ENGLAND JOURNAL OF MEDICINE, 2013, 368 (12): : 1101 - 1110
12345